The Need for Critical Examination of Disparities in Immunotherapy and Targeted Therapy Use Among Patients With Cancer
JAMA Oncol
.
2021 Aug 1;7(8):1115-1116.
doi: 10.1001/jamaoncol.2021.1322.
Authors
Sepideh Ashrafzadeh
1
,
Maryam M Asgari
1
2
,
Alan C Geller
3
Affiliations
1
Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts.
2
Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
3
Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
PMID:
34042941
DOI:
10.1001/jamaoncol.2021.1322
No abstract available
MeSH terms
Humans
Immunotherapy*
Molecular Targeted Therapy
Neoplasms* / therapy